Coave Therapeutics (Coave), a clinical-stage biotechnology company backed by international life science and strategic investors Seroba Life Sciences, Théa Open Innovation, eureKARE, Fund+, Omnes Capital, V-Bio Ventures, Kurma Partners, Idinvest, GO Capital, Sham Innovation Santé/Turenne, has strengthened its leadership team with the appointments of Thomas Blaettler MD, as Chief Medical

Neil Evans is to re-join Clifford Chance in January 2022 as a private equity partner based in London. Having originally practised at Clifford Chance, and then Simpson Thacher Bartlett, Evans re-joins from Mayer Brown’s private equity practice having advised on transactions with a range of clients, including Blackstone, KKR and

BGF has appointed Roshni Bandesha to the role of head of ESG and Sustainability. In her role at BGF, Bandesha will be responsible for embedding its sustainability strategy and integrating ESG within new and existing portfolio companies. She will report directly into executive chairman, Stephen Welton.   Bandesha has spent

The Riverside Company, a private investor focused on the smaller end of the middle-market, has appointed Allison Cole as Managing Director & Global Head, Fundraising and Investor Relations, leading Riverside’s expanding global fundraising and investor relations team.  Cole will build and cultivate Riverside’s relationships with investors and oversee the firm’s

Grain Management (Grain), a private equity firm focused on investments in the global communications sector, has appointed industry veteran Kevin Naughton as a Managing Director.  Former Chairman and Co-head of Credit Suisse’s Private Funds Group, Naughton’s role at Grain will focus on investor relations, with a particular focus on capital

The Riverside Company, a global private investor focused on the smaller end of the middle-market, has appointed Allison Cole as Managing Director & Global Head, Fundraising and Investor Relations, leading Riverside’s expanding global fundraising and investor relations team. Cole will build and cultivate Riverside’s relationships with investors and oversee the

Crestbridge has appointed Marta Ciemiega as Business Development Director, for the US.

Summit Partners, a global growth equity investor, has added JD Mullin to the firm’s Executive-in-Residence (EIR) programme.  In this role, Mullin will work closely with Summit’s technology team to identify new investment and leadership opportunities in growth-stage software companies. Mullin brings substantial experience in leading and scaling fast-growing SaaS businesses,

Essling Capital, an independent company specialising in private equity, is strengthening its team to support the development of its co-investment activity and increase its international presence.  Arnaud Lipkowicz joins as Partner of Essling Capital and Head of the Co-Investment activity, which has existed since the company’s inception. Lipkowicz has more